| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/12/2002 | US6346273 Process for solubilizing pharmaceutically active ingredients in water and in aqueous vehicles |
| 02/12/2002 | US6346271 Treatment of skin disorders using polymer sodium hyaluronate dermatitis. |
| 02/12/2002 | US6346270 Phenytoin therapy |
| 02/12/2002 | US6346268 Tablet for drug release |
| 02/12/2002 | US6346263 Particles and matrices of graft polymers |
| 02/12/2002 | US6346258 Physiological combination of active substances to enhance the skin's defenses against noxious agents |
| 02/12/2002 | US6346254 Cosmetic and pharmaceutical preparations comprising ascorbic acid derivatives |
| 02/12/2002 | US6346251 Antiproliferation agents for skin disorders |
| 02/12/2002 | US6346250 Composition and method useful for treating colic |
| 02/12/2002 | US6346242 Compounds and compositions for delivering active agents |
| 02/12/2002 | US6346233 Composition for treating cancer via liposomal aerosol formulation containing taxol |
| 02/12/2002 | US6346232 Aerosol formulation of beclomethasone-17,21-dipropionate, fluoroalkane propellants and ethanol |
| 02/12/2002 | CA2303685C Fluorocarbon aerosol medicaments |
| 02/12/2002 | CA2227194C Resolution of 1-azabicyclo[2.2.2]octan-3-amine, 2-(diphenylmethyl)-n-[[2-methoxy-5-(1-methylethyl)phenyl]methyl] |
| 02/12/2002 | CA2223776C Method of treatment for lung diseases using antisense oligonucleotides |
| 02/12/2002 | CA2221190C Novel substituted taxanes and pharmaceutical compositions containing them |
| 02/12/2002 | CA2193939C Useful form of anhydrous paroxetine hydrochloride |
| 02/12/2002 | CA2174105C Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 02/12/2002 | CA2131547C Composition for oral preparations |
| 02/12/2002 | CA2110273C Benzimidazole derivatives, their preparation process and their use in the fields of therapeutics and cosmetics |
| 02/12/2002 | CA2097317C Antiallergic piperdinyl benzimidazoles |
| 02/12/2002 | CA2094702C Substituted tetrahydropyridines and hydroxypiperidines as central nervous system agents |
| 02/12/2002 | CA2088742C Benzimidazole and imidazopyridine derivatives and their application |
| 02/12/2002 | CA2073453C Methods of enhancing wound healing and tissue repair |
| 02/12/2002 | CA2067877C Polycyclic amine compounds and their enantiomers, their method of preparation and pharmaceutical compositions in which they are present |
| 02/12/2002 | CA2057504C Process for preparing new n-acyl-2,3-benzodiazepine derivatives, their acid addition salts and pharmaceutical compositions containing the same |
| 02/12/2002 | CA2053705C Piperazine derivatives |
| 02/12/2002 | CA2048139C N-sulfonylindoline derivatives, their preparation and the pharmaceutical compositions in which they are present |
| 02/12/2002 | CA2043131C Brain resuscitation device and method for performing the same |
| 02/12/2002 | CA2024399C Compounds |
| 02/12/2002 | CA2018442C Antifungal 4-¬4-¬4-¬4-¬¬2-(2,4-difluorophenyl)-2-(1h-azolylmethyl)-1,3-dioxolan-4-yl|methoxy|phenyl|-1piperazinyl|triazolones and imidazolones |
| 02/12/2002 | CA2006891C Composition to induce and stimulate the growth of hair and/or slow down their shedding, based on pyrimidine derivatives and sun screens |
| 02/09/2002 | CA2354051A1 Ribosome structure and protein synthesis inhibitors |
| 02/09/2002 | CA2316330A1 Estrone and estrone esters as growth- and fat-deposition promoting compounds in humans |
| 02/07/2002 | WO2002010743A1 Improved anti-viral and anti-tumor chemotherapy by administration of erythropoeitin |
| 02/07/2002 | WO2002010426A1 Koji molds and use thereof for preparing cholesterol-lowering products |
| 02/07/2002 | WO2002010403A2 Regulation of human phosphatidylinositol-specific phospholipase c-like enzyme |
| 02/07/2002 | WO2002010382A2 Trp8, trp9 and trp10, markers for cancer |
| 02/07/2002 | WO2002010378A2 Antisense modulation of ptp1b expression |
| 02/07/2002 | WO2002010339A2 Gene expression profile for kshv infection and methods for treating same |
| 02/07/2002 | WO2002010322A1 Purifying crude pufa oils |
| 02/07/2002 | WO2002010216A2 Proteins and nucleic acids encoding same |
| 02/07/2002 | WO2002010214A2 Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same |
| 02/07/2002 | WO2002010191A2 Immunomodulatory compounds |
| 02/07/2002 | WO2002010188A1 16alpha-methyl or ethyl substituted estrogens |
| 02/07/2002 | WO2002010175A1 PYRROLO[2,1-b][1,3]BENZOTHIAZEPINES AND THEIR USE FOR THE PREPARATION OF MEDICAMENTS WITH ANTIPSYCHOTIC ACTIVITY |
| 02/07/2002 | WO2002010174A1 Process for the preparation of 9-amino substituted 9,10-dihydropyrrolo [2,1-b][1,3]benzotiazepines |
| 02/07/2002 | WO2002010173A1 Dihydroporphyrin derivatives and their uses |
| 02/07/2002 | WO2002010172A1 Azabicyclic compounds, preparation thereof and use as medicines, in particular as antibacterial agents |
| 02/07/2002 | WO2002010171A1 Crystalline therapeutic agent |
| 02/07/2002 | WO2002010170A1 Imidazo-pyrazine derivatives as ligands for gaba receptors |
| 02/07/2002 | WO2002010169A1 Piperazine derivatives |
| 02/07/2002 | WO2002010168A1 Novel guanidino derivatives as inhibitors of cell adhesion |
| 02/07/2002 | WO2002010167A1 Dementia remedies containing 2-aryl-8-oxodihydropurine derivatives as the active ingredient |
| 02/07/2002 | WO2002010166A1 Fused heterocyclic derivatives as phosphodiesterase inhibitors |
| 02/07/2002 | WO2002010165A1 Use of polycyclic aromatic compounds for making medicines capable of inhibiting telomerase |
| 02/07/2002 | WO2002010164A2 Dihydronaphthyridine- and dihydropyrrolopyridine-derivated compounds as potassium channel openers |
| 02/07/2002 | WO2002010163A1 Process for preparing azacycloalkanoylaminothiazoles |
| 02/07/2002 | WO2002010162A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl] carboxamide inhibitors of cyclin dependent kinases |
| 02/07/2002 | WO2002010161A1 Process for preparing arylacetylaminothiazoles |
| 02/07/2002 | WO2002010159A1 Lactam inhibitors of factor xa which are useful for the treatment of thrombosis |
| 02/07/2002 | WO2002010158A2 3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta |
| 02/07/2002 | WO2002010157A1 Benzofuran derivatives and their use as antibacterial agents |
| 02/07/2002 | WO2002010156A1 Benzofuran derivatives and their use as antibacterial agents |
| 02/07/2002 | WO2002010152A2 Novel indole derivatives and their use as medicaments |
| 02/07/2002 | WO2002010150A1 2,2-disubstituted 1,3-dioxolanes as antitussive agents |
| 02/07/2002 | WO2002010149A1 1,3-dioxolanes with antitussive activity |
| 02/07/2002 | WO2002010148A1 Novel coumarin derivatives and the salts thereof, a process for the preparation thereof and their use in the pharmaceutical field |
| 02/07/2002 | WO2002010146A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor |
| 02/07/2002 | WO2002010143A1 Non-steroidal inflammation inhibitors |
| 02/07/2002 | WO2002010142A1 Cyclic polyamine compounds for cancer therapy |
| 02/07/2002 | WO2002010141A1 Imidazole derivatives |
| 02/07/2002 | WO2002010140A2 Imidazolyl derivatives |
| 02/07/2002 | WO2002010139A1 Hexahydro-7-1h-azepin-2-yl-haxanoic acid derivatives as inhibitors of inducible nitric oxide synthase |
| 02/07/2002 | WO2002010137A2 Indazole derivatives as jnk inhibitors |
| 02/07/2002 | WO2002010136A1 3-substituted isoquinolin-1-yl derivatives |
| 02/07/2002 | WO2002010135A1 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient |
| 02/07/2002 | WO2002010125A1 Crystalline and pure modafinil, and process of preparing the same |
| 02/07/2002 | WO2002010120A1 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 02/07/2002 | WO2002010119A1 Preparation of sterile crystals of 5-aminolevulinic acid utilized for medical diagnostic and therapeutic purposes, and a device for facilitating this diagnostic process |
| 02/07/2002 | WO2002009815A2 New pharmaceutical composition |
| 02/07/2002 | WO2002009814A2 New use of lipase inhibitors |
| 02/07/2002 | WO2002009770A1 Use of rapamycin to inhibit immune response and induce tolerance to gene therapy vector and encoded transgene products |
| 02/07/2002 | WO2002009767A2 Therapeutic polyanhydride compounds for drug delivery |
| 02/07/2002 | WO2002009764A1 Combination compositions |
| 02/07/2002 | WO2002009762A2 Non-peptide ccr1 receptor antagonists in combination with cyclosporin a for the treatment of heart transplant rejection |
| 02/07/2002 | WO2002009761A2 Epoxy-steroidal aldosterone antagonist and calcium channel blocker combination therapy for treatment of congestive heart failure |
| 02/07/2002 | WO2002009760A2 Epoxy-steroidal aldosterone antagonist and beta-adrenergic antagonist combination therapy for treatment of congestive heart failure |
| 02/07/2002 | WO2002009759A2 Aldosterone antagonist and cyclooxygenase-2 inhibitor combination therapy to prevent or treat inflammation-related cardiovascular disorders |
| 02/07/2002 | WO2002009755A2 Apo-2l receptor agonist and cpt-11 synergism |
| 02/07/2002 | WO2002009740A1 Composition containing an iron complexing protein and a precursor of nitrogen monoxide metabolism and/or a chemical donor of nitrogen monoxide and uses thereof |
| 02/07/2002 | WO2002009736A1 Methods and agents for treating persistent pain |
| 02/07/2002 | WO2002009728A1 Methods of preventing or treating diseases and conditions using complex carbohydrates |
| 02/07/2002 | WO2002009727A1 Compositions and methods for improving cardiovascular function |
| 02/07/2002 | WO2002009726A1 Methods of treating conditions associated with insulin resistance with aicar, (5-amino-4-imidazole carboxamide riboside) and related compounds |
| 02/07/2002 | WO2002009724A1 Pharmaceutical compositions containing tobramycin and xanthan gum |
| 02/07/2002 | WO2002009723A2 Ammonium salts of hemoglobin allosteric effectors, and uses thereof |
| 02/07/2002 | WO2002009722A1 Anti-microbial compound |
| 02/07/2002 | WO2002009721A1 Method of increasing sensitivity of mammography |
| 02/07/2002 | WO2002009720A1 Inhibitors of dna polymerase sigma |